Literature DB >> 12924517

Relationship between chronic nasal and respiratory symptoms in patients with COPD.

Nicola J Roberts1, Simon J Lloyd-Owen, Fernando Rapado, Irem S Patel, Tom M A Wilkinson, Gavin C Donaldson, Jadwiga A Wedzicha.   

Abstract

The relationship between the upper and lower airways in chronic obstructive pulmonary disease (COPD) is unknown. We examined the prevalence of chronic nasal symptoms and the correlation with lower respiratory symptoms and parameters of severity of COPD such as exacerbation frequency and spirometry. 61 COPD patients from the East London COPD cohort were studied. [Mean (SD) age 70 (6.96) years, FEV1 0.98 (0.38) l, FVC 2.45 (0.72) l, FEV1%Pred 37.0 (12.3), and 47.6 (31.8) smoking pack years, 14 current smokers, 36 males]. COPD patients had a high prevalence of nasal symptoms (75%), more than half reporting nasal discharge (52.5%) and sneezing (45.9%). Associations were found between nasal score and daily sputum production (P = 0.005) and post-nasal drip and sputum production (P = 0.046) with a trend to increased nasal symptoms in frequent exacerbators compared to infrequent exacerbators. No significant relationship was found between nasal symptoms and FEV1 or any other lower respiratory airway symptom. Associations between nasal and respiratory symptoms were found suggesting that there is a relationship between the upper and lower airway in COPD.

Entities:  

Mesh:

Year:  2003        PMID: 12924517     DOI: 10.1016/s0954-6111(03)00114-8

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

Review 1.  Nasal manifestations of systemic illnesses.

Authors:  Isam Alobid; Jose Maria Guilemany; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2004-05       Impact factor: 4.806

2.  Evaluation of IL-8 nasal lavage levels and the effects of nasal involvement on disease severity in patients with stable chronic obstructive pulmonary disease.

Authors:  Hacer Celik; Serdar Akpinar; Hayriye Karabulut; Pinar Oktar; Berna Dursun; Huyla Celenk Erguden; Sibel Gunay; Tugrul Sipit
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

3.  Analysis of lower airway inflammation in a rabbit model of acute rhinosinusitis.

Authors:  Adin Selcuk; Ozgur Akdogan; Seren Gulsen Giray; Kursat Murat Ozcan; Ibrahim Ozcan; Huseyin Dere; Serdar Ensari; Candan Ozogul
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-11

4.  Chronic rhinosinusitis and risk of lung cancer in the Singapore Chinese Health Study.

Authors:  Woon-Puay Koh; Jian-Min Yuan; Renwei Wang; Adeline Seow; Hin-Peng Lee; Mimi C Yu
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

5.  Comparison of nasal and bronchial epithelial cells obtained from patients with COPD.

Authors:  David M Comer; J Stuart Elborn; Madeleine Ennis
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

Review 6.  Underrecognized comorbidities of chronic obstructive pulmonary disease.

Authors:  Joanna Miłkowska-Dymanowska; Adam J Białas; Anna Zalewska-Janowska; Paweł Górski; Wojciech J Piotrowski
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-15

Review 7.  The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease.

Authors:  Adam Jerzy Białas; Przemysław Sitarek; Joanna Miłkowska-Dymanowska; Wojciech Jerzy Piotrowski; Paweł Górski
Journal:  Oxid Med Cell Longev       Date:  2016-12-26       Impact factor: 6.543

8.  Frequency and effect of type 1 hypersensitivity in patients from India with chronic obstructive pulmonary disease and associated upper airways symptoms.

Authors:  Avi Kumar; Shekhar Kunal; Ashok Shah
Journal:  Asia Pac Allergy       Date:  2017-10-23

Review 9.  Cyclooxygenases and the pathogenesis of chronic rhinosinusitis and nasal polyposis.

Authors:  Josep M Guilemany; Jordi Roca-Ferrer; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2008-05       Impact factor: 4.919

10.  Inflammatory and cytotoxic effects of acrolein, nicotine, acetylaldehyde and cigarette smoke extract on human nasal epithelial cells.

Authors:  David M Comer; Joseph Stuart Elborn; Madeleine Ennis
Journal:  BMC Pulm Med       Date:  2014-03-01       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.